Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Wockhardt has reported that it will be launching azithromycin tablets in the US.
Subscribe to our email newsletter
Wockhardt received approval from the FDA for marketing the tablets containing 250mg, 500mg and 600mg azithromycin, which is used for treating various kinds of infections. Azithromycin is the generic name for the brand Zithromax, sold in the US by Pfizer.
Habil Khorakiwala, chairman of Wockhardt, said: “Development of azithromycin is a reflection of Wockhardt’s strong R&D for bulk drugs and formulations. This again is proof of Wockhardt’s commitment and dedication to developing innovative technologies, to capture opportunities in the US.”